The good thing about this one, for us in Health, is that there is long-term stable funding for transfers to provinces and territories, first of all. The second is in our primary responsibility, which is first nations' health. We have the budget for long-term predictable funding in this area. We have resources to provide more innovative services to first nations within that—accreditation is an example. Those, I think, are the highlights for us—a long-term stable area.
Other areas relate to better integration of our own services within the Public Health Agency and Health Canada, and in how we can better collaborate and work with similar resources internally, cutting down some of the red tape to provide better services. We've been able to make some improvements in that—in reducing red tape in processing applications, as an example.
So there are a number of great investments in health care.
At the same time, I think it has been very well received by the provinces and territories that they have long-term, stable, predictable funding that allows each jurisdiction to provide their own investments in areas of their priorities.
The other area is research. We have research funding. CIHR is providing funding to more than 10,000 research projects in our communities. That will also be very helpful in addressing some of the challenges we have in health care, particularly around tuberculosis. As an example, the pathways to health equity program is to basically bridge the health gaps between aboriginal people and the rest of Canadians. That program focuses on areas such as obesity, diabetes, oral health, suicide, and mental health, as well as tuberculosis.
This is the first time research investments are being made in partnership with aboriginal people. One key element that has changed is that we're not approving research projects in which aboriginal people are being studied from afar. It requires a partnership of health care researchers partnering with aboriginal people on the ground, so that we can bridge between traditional knowledge and modern medicine in how we address some of those challenges.
That area is very exciting, and it's new. I look forward to making some announcements around some of the proposals that are coming forward.
Thank you.